UnitedHealth Group Raises Profit Outlook After Q3 Earnings Gain

UnitedHealth Group raised its 2026 profit outlook after reporting third-quarter results above Wall Street expectations on Tuesday, October 13, 2026, as the healthcare company works to manage elevated medical costs through value-based care and artificial intelligence investments.

According to CNBC, the insurer expects adjusted 2026 earnings of at least $20.50 per share, up from its previous forecast of $19.50 to $20 per share. The company reported adjusted earnings of $4.69 per share and revenue of $112.69 billion.

UnitedHealth Group recorded third-quarter net income of $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, a year earlier, according to the company. Revenue declined from $113.16 billion in the prior-year quarter.

According to CNBC, UnitedHealth's medical cost ratio reached 88.4% in the third quarter, below analysts' expectation of 89.9%. The company said both UnitedHealthcare and Optum exceeded analysts' operating earnings estimates.

Wayne DeVeydt, UnitedHealth Group CFO, said the company is continuing a recovery plan focused on simplifying operations and expanding value-based care investments.

"You'll see in the quarter that we continue to execute not only on the financial aspects of our business, but really doing them with a simpler approach and an approach that's really focused on investing heavily in value-based care," said Wayne DeVeydt, CFO.

DeVeydt said medical expenses remain a challenge for insurers, particularly those operating privately run Medicare Advantage plans. He also noted costs linked to inpatient services and specialty pharmacy drugs remain elevated.

"Continue to be elevated versus historical norms" said Wayne DeVeydt, CFO.

DeVeydt added that recent improvements in the medical care ratio should be viewed alongside broader cost trends affecting the business.

"I think it's something we should keep an eye on. I think you'll see that our medical care ratio has improved quite a bit, but I don't want that to be misleading in terms of [medical cost trends]," said Wayne DeVeydt, CFO.

According to CNBC, UnitedHealth said value-based care programs helped shift patients toward lower-cost settings. Acute hospital admissions among members fell 15% year over year through the third quarter, while home health admissions rose 10%.

"You're finding more members are actually getting into a lower-cost care environment, but more importantly, they're getting into the care environment they actually want to be in. So we think we're really balancing both the quality and the cost." said Wayne DeVeydt, CFO.

Patient Capital Management highlighted UnitedHealth Group in its third-quarter 2026 investor letter, describing the company as a contributor to fund performance. The firm said UnitedHealth shares closed at $379.30 on October 9, 2026.

"Royalty Pharma (RPRX $56.21) and UnitedHealth Group Incorporated (NYSE:UNH) ($370.95) are significant contributors for the year, but we continue to like the risk-reward in each. United Healthcare is early in its earnings recovery with an excellent management team. For the next few years, earnings should grow in the mid-teens in most environments. Both companies add ballast to the portfolio." said Patient Capital Management in its Q3 2026 investor letter.

UnitedHealth's turnaround efforts include reducing membership, leaving unprofitable contracts, expanding value-based care, and deploying AI-powered tools to reduce administrative work for physicians, according to CNBC.